WuXi Biologics to Install Industry’s Largest Single-Use Bioreactor from ABEC at its New Commercial Manufacturing Facility

The 4,000L CSR is the largest single-use bioreactor size available in the industry and potentially largest-ever design in conventional disposable bioreactors, resulting in higher productivity and significantly lowering the cost of goods for cell culture-based biopharmaceuticals. The system also delivers performance comparable to stainless steel systems of that scale and can be fully customized for different products, resulting in higher cell culture productivity and faster process transfer and scale-up. With the scale-out strategy that WuXi Biologics pioneered in the industry to use multiple disposable bioreactors for commercial manufacturing, 4,000L CSRs will enable manufacturing up to the scale of 24,000L comparable to traditional stainless steel bioreactors yet still achieving the advantages of CAPEX and timeline reduction benefited from disposables.

Dr. Chris Chen, CEO of WuXi Biologics, said, “We are proud to be a global technology leader in bioprocessing and the first company in Asia to advance this exciting new technology. ABEC’s large volume single-use bioreactor greatly enhances our commercial manufacturing potential by allowing not only scale-out of capacity but also scale-up. In addition to the flexibility and time to market benefits of single-use manufacturing, we can now offer our clients true economies of scale and address biologics supply needs from kilograms to tons.”

“WuXi Biologics’ successful testing, evaluation and investment further validates ABEC’s CSR technology as one of the most flexible single-use solutions available on the market,” said Scott Pickering, ABEC President and CEO. “We are pleased to be part of their next-generation manufacturing strategy, and look forward to continuing this long-term partnership.”